Skip to main content

Day: October 21, 2025

HII Increases Quarterly Dividend to $1.38 per Share

NEWPORT NEWS, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.38 per share, a $0.03 increase over the $1.35 per share dividend paid in each of the prior four quarters. The $1.38 per share dividend will be payable on Dec. 12, 2025, to shareholders of record as of the close of business on Nov. 28, 2025. About HII HII is a global, all-domain defense provider. HII’s mission is to deliver the world’s most powerful ships and all-domain solutions in service of the nation, creating the advantage for our customers to protect peace and freedom around the world. As the nation’s largest military shipbuilder, and with a more than 135-year history of advancing U.S. national security, HII delivers critical capabilities extending from ships to unmanned...

Continue reading

Genius Group Title Sponsor of Coindesk’s Bitcoin Treasury Month, Awarding 100 Million Satoshis in Prize Money

Genius Group LimitedPublic Firm Bitcoin Holdings Top 1 Million BTCSINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it is the Title Sponsor of Coindesk’s Bitcoin Treasury Theme Month, with 100 million Satoshis (equal to one Bitcoin) in prize money. CoinDesk, a leading site for Bitcoin, Blockchain and Crypto news, is featuring articles and news focused on Bitcoin Treasury companies from October 20, 2025 through to November 30, 2025 as part of its Bitcoin Treasury Theme Month. As the Title Sponsor of Coindesk’s Bitcoin Treasury Theme Month, Genius Group will feature its Bitcoin education programs on Coindesk’s site throughout the month, with a special focus on the Company’s Bitcoin...

Continue reading

CEA Industries ($BNC) Crosses Half-Million BNB Milestone

Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount of $435 million and an estimated BNB value of $546.8million as of 1:00PM ET, October 20, 2025. In addition, the Company retains approximately $50million in unencumbered cash and cash equivalents, bringing total crypto and cash holdings to $596.8 million. This latest acquisition further reinforces its position as the world’s largest BNB treasury company and moving it closer to its stated goal of owning 1% of total supply by the end of 2025. BNB has gained renewed momentum in recent weeks, even as the broader crypto market struggles to find stability, this was...

Continue reading

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of 1,746,631 common shares (or common share equivalents in lieu thereof) in a registered direct offering (the “Offering”) at a purchase price of US$0.63 per common share. The closing of the Offering is expected to occur on or about October 22, 2025, subject to the satisfaction of customary closing conditions and approval from the TSX Venture Exchange. The gross proceeds from the Offering are expected to be US$1.1 million,...

Continue reading

Invitation to Lassila & Tikanoja’s Capital Markets Day on 26 November 2025

Lassila & Tikanoja plcInvestor News21 October 2025 at 3.00 PM Invitation to  Lassila & Tikanoja’s Capital Markets Day on 26 November 2025 L&T has the pleasure of inviting analysts and investors to its Capital Markets Day in Helsinki, Finland, on Wednesday, 26 November 2025. The event will focus on New L&T and Luotea as separate businesses, and their further value creation potential following L&T’s Board of Directors’ decision to propose to separate New L&T as a new standalone listed company on or about 31 December 2025*.New L&T is positioned as a Circular Economy leader in the Nordics with multiple growth avenues identified for substantial value creation opportunities. Luotea is an established Nordic facility services player with an improved operating model geared for growth.The Capital Markets Day...

Continue reading

Selskabsmeddelelse nr. 11/2025 – Offentliggørelse af regnskabstal per 30. september 2025

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10 Brøndby, den 21. oktober 2025 SELSKABSMEDDELELSE NR. 11/2025 Offentliggørelse af regnskabstal per 30. september 2025 I forbindelse med den ordinære generalforsamling den 21. oktober 2025 offentliggør Brøndbyernes I.F. Fodbold A/S udvalgte foreløbige, ikke-reviderede regnskabstal for 1. kvartal af regnskabsåret 2025/26, som dækker perioden 1. juli til 30. september 2025. Offentliggørelsen sker som en enkeltstående orientering til markedet og indebærer ikke en ændring i selskabets rapporteringspraksis. Brøndbyernes I.F. Fodbold A/S har ikke tidligere offentliggjort kvartalsregnskaber siden 2019 og har ikke planer om at offentliggøre kvartalsvise regnskabsrapporter fremover. Tallene præsenteres i nedenstående forkortede balanceopgørelse pr. 30. september 2025:Aktiver MDKK Passiver MDKK           Egenkapital 326       Immaterielle...

Continue reading

GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio

GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — GLD Partners, LP, with a growing footprint of investments in life sciences, healthcare, and biotech, today announced the successful acquisition of select assets from Seelos Therapeutics, Inc. through the Chapter 11 bankruptcy process. Following its acquisition of Seelos’ senior secured debt, GLD served as the stalking horse bidder in the U.S. Bankruptcy Court in the Southern District of New York, and emerged as the successful acquirer through a Section 363 sale. The transaction includes Seelos’ late-stage ketamine and trehalose programs, both representing high-value opportunities in central nervous system (CNS) and rare disease therapeutics. “Seelos’ ketamine...

Continue reading

Novo Nordisk announces an Extraordinary General Meeting to be convened to elect new members of the Board of Directors

Bagsværd, Denmark, 21 October 2025 – Novo Nordisk today announced that the Board of Directors have decided to convene an Extraordinary General Meeting to elect new members of the Board of Directors of Novo Nordisk. “Following dialogue with the Novo Nordisk Foundation regarding the future composition of the Board of Directors, it has not been possible to reach a common understanding. The Board proposed a renewal focusing on addition of select, new competencies while also maintaining continuity, whereas the Board of the Foundation wanted a more extensive reconfiguration. After thorough deliberation and considering the Foundation’s position and control of the majority of votes in Novo Nordisk, the Board concluded that it is in the best interest of the company and its shareholders to convene an Extraordinary General Meeting to elect...

Continue reading

Discovery Announces Resource Development Agreement with Taykwa Tagamou Nation

RDA Agreement establishes framework for a cooperative, mutually beneficial and respectful relationship between Discovery and TTN TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced that the Company and Taykwa Tagamou Nation (“TTN”) have entered into a Resource Development Agreement (“RDA”). The RDA is intended to establish a framework for ongoing consultation and communication for the purpose of establishing a cooperative, mutually beneficial and respectful relationship between the parties and provide a basis for support of Discovery’s mining and mineral processing activities within TTN’s traditional territory. Tony Makuch, Discovery’s CEO, commented: “We are honored to have entered into this agreement with TTN and wish to thank the band council...

Continue reading

Beneficient Reports Results for First Quarter Fiscal 2026

First quarter results highlight improved cost management, new primary capital transactions and strengthened financial foundation DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today reported its financial results for the fiscal 2026 first quarter, which ended June 30, 2025. Commenting on the fiscal 2026 first quarter results, interim Chief Executive Officer James Silk said: “This quarter reflects meaningful progress strengthening Beneficient’s financial and operational foundation. We’ve taken deliberate steps to reduce expenses, complete new primary capital transactions and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.